NCT01759849View on ClinicalTrials.gov

Effect of in Vitro Blocking the Common Beta Chain on Cell Viability in Asthma

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Asthma
Interventions
OTHER

Allergen

Allergen extract is administered by inhalation.

Trial Locations (1)

L8N 3Z5

McMaster University Medical Center, Hamilton

All Listed Sponsors
collaborator

CSL Limited

INDUSTRY

lead

Hamilton Health Sciences Corporation

OTHER

NCT01759849 - Effect of in Vitro Blocking the Common Beta Chain on Cell Viability in Asthma | Biotech Hunter | Biotech Hunter